RGEDF (Chemical Works of Gedeon Richter) EV-to-FCF: 20.02 (As of Jun. 27, 2026) — Near Median


RGEDF Chemical Works of Gedeon Richter PLC RGEDF
94 GF Score
Price $39.59
GF Value $35.22
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Chemical Works of Gedeon Richter EV-to-FCF?

Chemical Works of Gedeon Richter RGEDF -1.78% 94 EV-to-FCF is 20.02 as of Jun. 27, 2026, which is 2% above its 10-year median of 19.69. GuruFocus rates RGEDF with a GF Score™ of 94/100 and a GF Value™ of $35.22 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 562 Drug Manufacturers companies, Chemical Works of Gedeon Richter ranks better than 51.96% on this metric.

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Chemical Works of Gedeon Richter's Enterprise Value is $6,402 Mil. Chemical Works of Gedeon Richter's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $320 Mil. Therefore, Chemical Works of Gedeon Richter's EV-to-FCF for today is 20.02.

The historical rank and industry rank for Chemical Works of Gedeon Richter's EV-to-FCF or its related term are showing as below:

RGEDF' s EV-to-FCF Range Over the Past 10 Years
Min: -471.49   Med: 19.69   Max: 60.27
Current: 19.38

During the past 13 years, the highest EV-to-FCF of Chemical Works of Gedeon Richter was 60.27. The lowest was -471.49. And the median was 19.69.

RGEDF's EV-to-FCF is ranked better than
51.96% of 562 companies
in the Drug Manufacturers industry
Industry Median: 20.11 vs RGEDF: 19.38

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-06-27), Chemical Works of Gedeon Richter's stock price is $39.5888. Chemical Works of Gedeon Richter's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $2.147. Therefore, Chemical Works of Gedeon Richter's PE Ratio (TTM) for today is 18.44.


Chemical Works of Gedeon Richter  (OTCPK:RGEDF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Chemical Works of Gedeon Richter's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=39.5888/2.147
=18.44

Chemical Works of Gedeon Richter's share price for today is $39.5888.
Chemical Works of Gedeon Richter's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.147.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Chemical Works of Gedeon Richter EV-to-FCF Related Terms


Chemical Works of Gedeon Richter EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Chemical Works of Gedeon Richter's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chemical Works of Gedeon Richter EV-to-FCF Chart

Chemical Works of Gedeon Richter Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -469.79 12.67 53.31 8.30 7.47

Chemical Works of Gedeon Richter Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.09 8.30 15.86 17.43 7.47

RGEDF vs ZTS, UTHR, VTRS: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chemical Works of Gedeon Richter EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Chemical Works of Gedeon Richter's EV-to-FCF falls into.


RGEDF
94GF Score
Chemical Works of Gedeon Richter PLC RGEDF
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chemical Works of Gedeon Richter EV-to-FCF Calculation

Chemical Works of Gedeon Richter's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=6402.167/319.76
=20.02

Chemical Works of Gedeon Richter's current Enterprise Value is $6,402 Mil.
Chemical Works of Gedeon Richter's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $320 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-FCF →
What does a EV-to-FCF of 20.02 mean?
Chemical Works of Gedeon Richter (RGEDF) has a EV-to-FCF of 20.02 as of Jun. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Chemical Works of Gedeon Richter and its competitors. This is near median its historical median of 19.69. According to the industry distribution chart, Chemical Works of Gedeon Richter ranks #270 out of 562 companies in the Drug Manufacturers industry, placing it in the top 48%.
Is Chemical Works of Gedeon Richter's EV-to-FCF too high?
Chemical Works of Gedeon Richter's current EV-to-FCF of 20.02 is near median its 10-year median of 19.69. The Drug Manufacturers industry median EV-to-FCF is 20.11. Chemical Works of Gedeon Richter's value of 20.02 is 0.4% below this industry median. Based on the distribution chart, Chemical Works of Gedeon Richter ranks #270 out of 562 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Chemical Works of Gedeon Richter has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Chemical Works of Gedeon Richter's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Chemical Works of Gedeon Richter ranks #270 out of 562 companies for EV-to-FCF. This puts Chemical Works of Gedeon Richter in the upper half of its industry. The industry median EV-to-FCF is 20.11. Chemical Works of Gedeon Richter's value of 20.02 is 0.4% below this benchmark. While the company's 10-year median is 19.69 vs. the industry median of 20.11, Chemical Works of Gedeon Richter has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.11, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chemical Works of Gedeon Richter's current EV-to-FCF of 20.02 is 0.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Chemical Works of Gedeon Richter and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chemical Works of Gedeon Richter's current EV-to-FCF is 20.02, which is near median its own 10-year median of 19.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chemical Works of Gedeon Richter stock overvalued right now?
Based on GuruFocus' analysis, Chemical Works of Gedeon Richter (RGEDF) is currently considered Modestly Overvalued. The stock's GF Value™ is $35.22, compared to a current price of $39.59 — trading 12.4% above its estimated fair value. The current EV-to-FCF is 20.02, which is near median its 10-year median of 19.69 and 0.4% below the Drug Manufacturers industry median of 20.11. Chemical Works of Gedeon Richter's overall GF Score™ is 94/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Chemical Works of Gedeon Richter (RGEDF), the current EV-to-FCF is 20.02 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Chemical Works of Gedeon Richter (RGEDF) Overvalued in 2026?

Based on GuruFocus' analysis, Chemical Works of Gedeon Richter stock appears to be overvalued. The current stock price of $39.59 is trading 12.4% above its estimated GF Value™ of $35.22. GuruFocus considers Chemical Works of Gedeon Richter to be Modestly Overvalued.

Key valuation signals for RGEDF:

  • EV-to-FCF: 20.02 (near median its 10-year median of 19.69)
  • GF Value™: $35.22 vs. price of $39.59 (12.4% above fair value)
  • GF Score™: 94/100 with 3 warning signs
  • Industry Position: 0.4% below the Drug Manufacturers median (#270 of 562)

No single metric tells the full story. See the RGEDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Chemical Works of Gedeon Richter Business Description

Address Gyomroi ut 19-21, Budapest, HUN, 1103
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular, and central nervous system products. It manufactures medicines including original, generic and licensed products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharma segment comprising Women's Healthcare, Neuropsychiatry, Biotechnology, General Medicine, and Other pharma; and the Others segment includes the remaining wholesale and retail business of the Group and all other activities. The company operates internationally.
94GF Score

Get the complete analysis for RGEDF

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$39.59
Price
$35.22
GF Value